• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapy.

作者信息

Milano G, Etienne M C

机构信息

Centre Antoine-Lacassagne, Nice, France.

出版信息

Pharmacogenetics. 1994 Dec;4(6):301-6. doi: 10.1097/00008571-199412000-00002.

DOI:10.1097/00008571-199412000-00002
PMID:7704035
Abstract
摘要

相似文献

1
Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapy.
Pharmacogenetics. 1994 Dec;4(6):301-6. doi: 10.1097/00008571-199412000-00002.
2
Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency.
Trends Pharmacol Sci. 1995 Oct;16(10):325-7. doi: 10.1016/s0165-6147(00)89065-3.
3
Determination of dihydropyrimidine dehydrogenase (DPD) in fibroblasts of a DPD deficient pediatric patient and family members using a polyclonal antibody to human DPD.使用针对人二氢嘧啶脱氢酶（DPD）的多克隆抗体，测定一名DPD缺乏的儿科患者及其家庭成员成纤维细胞中的二氢嘧啶脱氢酶（DPD）。
Adv Exp Med Biol. 1994;370:7-10. doi: 10.1007/978-1-4615-2584-4_2.
4
Dihydropyrimidine dehydrogenase deficiency. Identification of two novel mutations and expression of missense mutations in E. coli.二氢嘧啶脱氢酶缺乏症。两种新突变的鉴定及错义突变在大肠杆菌中的表达。
Adv Exp Med Biol. 1998;431:341-6.
5
Clinical and biochemical abnormalities in a patient with dihydropyrimidine dehydrogenase deficiency due to homozygosity for the C29R mutation.
J Inherit Metab Dis. 1999 Apr;22(2):191-2. doi: 10.1023/a:1005470524203.
6
Assignment of the human dihydropyrimidine dehydrogenase gene (DPYD) to chromosome region 1p22 by fluorescence in situ hybridization.通过荧光原位杂交将人类二氢嘧啶脱氢酶基因（DPYD）定位于染色体区域1p22。
Genomics. 1994 Dec;24(3):613-4. doi: 10.1006/geno.1994.1680.
7
Dihydropyrimidine dehydrogenase deficiency in a Hutterite newborn.
Adv Exp Med Biol. 1991;309B:311-4. doi: 10.1007/978-1-4615-7703-4_69.
8
Dihydropyrimidine dehydrogenase (DPD) deficiency: identification and expression of missense mutations C29R, R886H and R235W.二氢嘧啶脱氢酶（DPD）缺乏症：错义突变C29R、R886H和R235W的鉴定与表达
Hum Genet. 1997 Dec;101(3):333-8. doi: 10.1007/s004390050637.
9
Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine uracilurea.药物代谢中的人类多态性：二氢嘧啶脱氢酶基因突变导致外显子跳跃和胸腺嘧啶尿症。
DNA Cell Biol. 1995 Jan;14(1):1-6. doi: 10.1089/dna.1995.14.1.
10
Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil (review).二氢嘧啶脱氢酶（DPD）与5-氟尿嘧啶的临床药理学（综述）
Anticancer Res. 1994 Nov-Dec;14(6A):2295-7.

引用本文的文献

1
Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients.在使用尿血症进行基于治疗前表型的二氢嘧啶脱氢酶（DPD）缺乏症筛查中肾功能损害和肝功能检查异常：一项针对1138例患者的基于人群的综合研究
Ther Adv Med Oncol. 2023 Jan 10;15:17588359221148536. doi: 10.1177/17588359221148536. eCollection 2023.
2
Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis.基于尿嘧啶表型分析的二氢嘧啶脱氢酶（DPD）缺乏症筛查指南对降低5-氟尿嘧啶化疗严重副作用的影响：一项倾向评分分析
Pharmaceutics. 2022 Oct 6;14(10):2119. doi: 10.3390/pharmaceutics14102119.
3
Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics.化疗反应和毒性的预测因素：药物基因组学。
Semin Colon Rectal Surg. 2008 Dec;19(4):226-230. doi: 10.1053/j.scrs.2008.09.007.
4
Crystallization and preliminary X-ray data analysis of beta-alanine synthase from Drosophila melanogaster.黑腹果蝇β-丙氨酸合酶的结晶及初步X射线数据分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Oct 1;63(Pt 10):874-7. doi: 10.1107/S1744309107042984. Epub 2007 Sep 19.
5
How may anticancer chemotherapy with fluorouracil be individualised?氟尿嘧啶的抗癌化疗如何实现个体化？
Clin Pharmacokinet. 2006;45(6):567-92. doi: 10.2165/00003088-200645060-00002.
6
Purification, crystallization and X-ray diffraction analysis of dihydropyrimidinase from Dictyostelium discoideum.盘基网柄菌二氢嘧啶酶的纯化、结晶及X射线衍射分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Jan 1;62(Pt 1):36-8. doi: 10.1107/S174430910503976X. Epub 2005 Dec 16.
7
Crystallization and X-ray diffraction analysis of dihydropyrimidinase from Saccharomyces kluyveri.克鲁维酵母二氢嘧啶酶的结晶及X射线衍射分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Apr 1;61(Pt 4):359-62. doi: 10.1107/S174430910500610X. Epub 2005 Mar 12.
8
Dihydropyrimidine amidohydrolases and dihydroorotases share the same origin and several enzymatic properties.二氢嘧啶酰胺水解酶和二氢乳清酸酶有着相同的起源和若干酶学性质。
Nucleic Acids Res. 2003 Mar 15;31(6):1683-92. doi: 10.1093/nar/gkg258.
9
Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines.伊立替康、氟尿嘧啶-亚叶酸和奥沙利铂的三联组合：对人结肠癌细胞系的研究结果
Br J Cancer. 2001 Feb;84(4):579-85. doi: 10.1054/bjoc.2000.1600.
10
Cardiotoxicity of the antiproliferative compound fluorouracil.抗增殖化合物氟尿嘧啶的心脏毒性。
Drugs. 1999 Apr;57(4):475-84. doi: 10.2165/00003495-199957040-00003.